Efficacy and safety of Nirmatrelvir/Ritonavir for treating the Omicron variant of COVID-19

ObjectiveTo evaluate the efficacy and safety of Nirmatrelvir/Ritonavir in the treatment of the Omicron variant of coronavirus disease 2019 (COVID-19).MethodsData from 58 patients who were infected with the Omicron variant of COVID-19 were retrospectively collected. The patients were divided into two...

Full description

Bibliographic Details
Published in:Frontiers in Medicine
Main Authors: Chaochao Qiu, Zhengxing Wu, Xiaojing Liu, Qiang Zhang, Lianpeng Wu, Xinchun Ye, Jiajun Zhou, Jichan Shi, Xiangao Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Subjects:
COVID-19
Omicron variant
Nirmatrelvir/Ritonavir
efficacy
adverse effect
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1161193/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1161193/full

Similar Items